| Literature DB >> 30449674 |
Yu Ohki1, Hidetaka Sakurai2, Madoka Hoshino3, Hideki Terashima4, Hiroki Shimizu5, Tomio Ishikawa5, Tomoko Ogiyama6, Yasunori Muramatsu5, Toshiyuki Nakanishi3, Shojiro Miyazaki1, Hiroyuki Tsuruoka3, Hideki Kobayashi7, Kazuishi Kubota8.
Abstract
Molecular target identification of small molecules, so-called target deconvolution, is a major obstacle to phenotype-based drug discovery. Here, we developed an approach called perturbation-based proteomic correlation profiling (PPCP) utilizing the correlation between protein quantity and binding activity of compounds under cellular perturbation by gene silencing and successfully identified lanosterol synthase as a molecular target of TGF-β pathway inhibitor. This PPCP concept was extended to the use of a cell line panel and provides a new option for target deconvolution.Entities:
Keywords: TGF-β pathway inhibitor; cell line panel; chemical proteomics; gene knockdown; lanosterol synthase; mass spectrometry; perturbation-based proteomic correlation profiling; phenotype-based drug discovery; radioactive compound binding assay; target deconvolution
Mesh:
Substances:
Year: 2018 PMID: 30449674 DOI: 10.1016/j.chembiol.2018.10.012
Source DB: PubMed Journal: Cell Chem Biol ISSN: 2451-9448 Impact factor: 8.116